AbbVie Inc (ABBV)

ABBV (NYSE:Drugs) EQUITY
$61.86
neg -0.13
-0.21%
Today's Range: 61.10 - 62.04 | ABBV Avg Daily Volume: 8,146,000
Last Update: 01/17/17 - 4:01 PM EST
Volume: 8,436,667
YTD Performance: -1.21%
Open: $61.75
Previous Close: $61.99
52 Week Range: $51.60 - $68.12
Oustanding Shares: 1,625,099,012
Market Cap: 100,739,887,754
6-Month Chart
TheStreet Ratings Grade for ABBV
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 5 5 6
Moderate Buy 1 1 1 1
Hold 8 8 8 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.50 2.40 2.40 2.27
Latest Dividend: 0.64
Latest Dividend Yield: 4.13%
Dividend Ex-Date: 01/11/17
Price Earnings Ratio: 16.75
Price Earnings Comparisons:
ABBV Sector Avg. S&P 500
16.75 16.80 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
2.86% 7.88% 23.57%
GROWTH 12 Mo 3 Yr CAGR
Revenue 14.50 0.20 0.07
Net Income 190.00 0.00 -0.01
EPS 184.50 -0.10 -0.02
Earnings for ABBV:
EBITDA 8.37B
Revenue 22.86B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $1.20 $1.25 $4.82 $5.49
Number of Analysts 10 3 11 9
High Estimate $1.26 $1.28 $4.85 $5.53
Low Estimate $1.17 $1.21 $4.80 $5.44
Prior Year $1.13 $1.15 $4.29 $4.82
Growth Rate (Year over Year) 6.11% 8.99% 12.40% 13.93%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Bret Jensen

 | Jan 17, 2017 | 11:00 AM EST
Deals already are popping up, and we'll soon have earnings reports from the industry giants.
RMPIA
By

Bret Jensen

 | Jan 12, 2017 | 11:00 AM EST
But the 3% drop in the sector yesterday is clearly an overreaction to Trump's comments.
RMPIA
By

Bret Jensen

 | Dec 16, 2016 | 8:58 AM EST
We touched briefly on housing in our first post this morning. There are still some cheap home-building stocks if the housing market continues to improve, which I expect as I believe economic growth will pick up in 2017. I have done well with this segment of the market in 2016 and I still believe there is value here.
By

Bruce Kamich

 | Dec 12, 2016 | 11:18 AM EST
Overall, the next move for ABBV looks like it will be to the upside.
RMPIA
By

Guy Ortmann

 | Nov 14, 2016 | 12:27 PM EST
What stocks have changed direction in the past week.
RMPIA
By

David Peltier

 | Nov 10, 2016 | 1:30 PM EST
Check out these 15 stocks that boast solid dividend yields and are growing earnings.
RMPIA
By

Jim Cramer

 | Nov 1, 2016 | 4:09 PM EDT
Today there was a virtual vacuum of good news in the stock market.
By

Jim Cramer

 | Nov 1, 2016 | 7:01 AM EDT
We have to ask: where is the cash flow to pay off the debt, if any important prices are rolled back?

bearishAbbvie downgraded at Credit Suisse

Oct 31, 2016 | 8:19 AM EDT
ABBV was downgraded from Outperform to Neutral, Credit Suisse said. $60 price target. Humira longevity concerns are increasing.
RMPIA
By

Jim Cramer

 | Oct 28, 2016 | 12:00 PM EDT
McKesson's disappointing earnings report ignited a selloff in health care stocks, and Jim Cramer says investors are questioning the sector's future.
Shares of PG area trading at new January highs this afternoon.  The stock is up over ...
Market slightly down across the board to start the holiday shortened trading week.  N...
This morning, Morgan Stanley reported solid results for Q4, ahead of estimates for both re...
See my Jan. 12, 2017 Real Money Pro article for details on my thought process regarding Ch...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.